tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
Holding TNYA?
Track your performance easily

Tenaya Therapeutics (TNYA) Ownership - Who Owns Tenaya Therapeutics?

1,381 Followers

Tenaya Therapeutics (TNYA) Ownership Overview

59.66%11.43%1.94%7.12%19.84%
59.66% Insiders
1.94% Other Institutional Investors
7.12% ETFs
19.84% Public Companies and Individual Investors
The ownership structure of Tenaya Therapeutics (TNYA) stock is a mix of institutional, retail, and individual investors. Approximately 20.50% of the company’s stock is owned by Institutional Investors, 59.66% is owned by Insiders, and 19.84% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 19, 2024
Chihiro Saito
Svp, Accounting And Fin. Ops.
xxxxxxxxxxxxx
$6829
Aug 16, 2024
Faraz Ali
Ceo,director
xxxxxxxxxxxxx
$28172
Feb 16, 2024
Faraz Ali
Ceo,director
xxxxxxxxxxxxx
$37258
Feb 16, 2024
xxxxxxxxxxxxx
$27431

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$50303
Jun 30, 2024
xxxxxxxxxxxxx
$315322
Jun 30, 2024
xxxxxxxxxxxxx
$23629275

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
22,999,565Insider29.03%59,108,882
22,999,565Insider29.03%59,108,882
7,622,347Institution9.62%19,589,432
3,053,877Institution3.85%7,848,464
2,755,771Institution3.48%7,082,331
2,570,794Institution3.25%6,606,941
2,178,860Institution2.75%5,599,670
1,230,913Institution1.55%3,163,446
631,474Institution0.80%1,622,888
564,101Insider0.71%1,449,740

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,755,771Institution3.48%7,082,331
2,570,794Institution3.25%6,606,941
1,230,913Institution1.55%3,163,446
631,474Institution0.80%1,622,888
512,123Institution0.65%1,316,156
267,046Institution0.34%686,308
264,730Institution0.33%680,356
156,900Institution0.20%403,233
152,588Institution0.19%392,151
80,377Institution0.10%206,569

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,064,246Institution2.61%3,983,995
1,518,945Institution1.92%3,903,689
691,525Institution0.87%1,334,643
379,749Institution0.48%975,955
252,778Institution0.32%487,862
170,501Institution0.22%470,583
140,287Institution0.18%360,538
123,950Institution0.16%318,552
78,479Institution0.10%216,602
30,202Institution0.04%83,358

FAQ

Who Owns Tenaya Therapeutics (TNYA)?
According to the latest TipRanks data, approximately 1.94% of the company's stock is held by institutional investors, 59.66% is held by insiders, and 19.84% is held by retail investors.
    What percentage of Tenaya Therapeutics (TNYA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.94% of Tenaya Therapeutics (TNYA) stock is held by institutional investors.
      What percentage of Tenaya Therapeutics (TNYA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 19.84% of Tenaya Therapeutics (TNYA) stock is held by retail investors.
        Who owns the most shares of Tenaya Therapeutics (TNYA)?
        COLUMN GROUP III GP, LP owns the most shares of Tenaya Therapeutics (TNYA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis